Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

May 21, 2024

BUY
$6.01 - $8.93 $3,912 - $5,813
651 Added 108.5%
1,251 $7,000
Q3 2023

Oct 30, 2023

BUY
$6.01 - $8.93 $3,912 - $5,813
651 Added 108.5%
1,251 $8,000
Q2 2023

May 21, 2024

SELL
$3.94 - $6.27 $70 - $112
-18 Reduced 2.91%
600 $3,000
Q2 2023

Jul 27, 2023

SELL
$3.94 - $6.27 $70 - $112
-18 Reduced 2.91%
600 $4,000
Q1 2023

May 21, 2024

BUY
$4.77 - $9.16 $734 - $1,410
154 Added 33.19%
618 $2,000
Q1 2023

Apr 27, 2023

BUY
$4.77 - $9.16 $734 - $1,410
154 Added 33.19%
618 $3,000
Q4 2022

May 21, 2024

BUY
$8.17 - $12.95 $3,790 - $6,008
464 New
464 $4,000
Q4 2022

Jan 31, 2023

BUY
$8.17 - $12.95 $302 - $479
37 Added 8.67%
464 $4,000
Q3 2022

Oct 21, 2022

BUY
$11.4 - $17.18 $4,867 - $7,335
427 New
427 $5,000

Others Institutions Holding PMVP

About PMV Pharmaceuticals, Inc.


  • Ticker PMVP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,622,600
  • Market Cap $73.5M
  • Description
  • PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also d...
More about PMVP
Track This Portfolio

Track China Universal Asset Management Co., Ltd. Portfolio

Follow China Universal Asset Management Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of China Universal Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on China Universal Asset Management Co., Ltd. with notifications on news.